Indacaterol Maleate News
Indacaterol Maleate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Indacaterol Maleate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Ulunar Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
- Evidence level: L5
- Predicted indications (20):
- nephrogenic syndrome of inappropriate antidiuresis (99.5%)
- headache disorder (99.5%)
- trigeminal autonomic cephalalgia (99.3%)
- paratenonitis (99.3%)
- calcific tendinitis (99.2%)
- hypertrichosis (disease) (99.2%)
- bronchial disease (99.2%)
- myositis (99.1%)
- anaphylaxis (99.1%)
- Ambras type hypertrichosis universalis congenita (99.1%)
- renin-angiotensin-aldosterone system-blocker-induced angioedema (99.0%)
- malformation syndrome with odontal and/or periodontal component (99.0%)
- syndrome with a Dandy-Walker malformation as major feature (99.0%)
- rheumatoid arthritis (99.0%)
- manic bipolar affective disorder (99.0%)
- isolated genetic hair shaft abnormality (98.9%)
- severe pre-eclampsia (98.9%)
- exostosis (98.9%)
- hypotrichosis simplex of the scalp (98.9%)
- idiopathic granulomatous myositis (98.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.